Our Latest News

[NEWS] – Biofortis obtains ANSM authorization and strengthens its position in the development of microbiota-derived therapies

Biofortis announces that it has obtained authorization from the French National Agency for the Safety of Medicines and Health Products (ANSM) for its activities involving the collection of human stool samples intended for the preparation of fecal microbiota for...
Pharmabiotics 2020

Pharmabiotics 2020

Pharmabiotics 2020   March 10/11th Biofortis team will attend Pharmabiotics 2020 March 10-11th of March : focused on...

AFCRO – EUCROF

BIOFORTIS will be present at AFCRO - 9th day of Clinical Research - 30th of january We will be in force with certain...

Explore

our success stories

Contact

our team

Discover

our capabilities